Abstract
Heart failure remains a leading cause of death and disability, requiring early development of new therapies. In addition to peripheral manifestations, central dysfunction leads to an exaggerated sympathetic tone emanating from central cardiovascular regulating nuclei. Research has shown that transplantation of bone marrow-derived mesenchymal stromal cells (MSCs) is a promising new approac…